GlobeNewswire: GeneThera, Inc. Contains the last 10 of 7 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T11:48:35ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2009/05/26/398172/166043/en/GeneThera-Updates-Its-Shareholders-and-Investing-Public.html?f=22&fvtc=4&fvtv=6176GeneThera Updates Its Shareholders and Investing Public2009-05-26T11:30:00Z<![CDATA[ARVADA, Colo., May 26, 2009 (GLOBE NEWSWIRE) -- GeneThera, Inc. is a public company actively trading on the OTC (Pink Sheets:GTHR). As a service and advisory to our shareholders, along with the investing public, we are addressing our recent events since February to keep our investment market informed.
]]>https://www.globenewswire.com/news-release/2009/02/13/392619/159624/en/GeneThera-to-Attend-Western-Veterinary-Conference-in-Las-Vegas.html?f=22&fvtc=4&fvtv=6176GeneThera to Attend Western Veterinary Conference in Las Vegas2009-02-13T16:53:20Z<![CDATA[WHEAT RIDGE, Colo. and NEWPORT BEACH, Calif., Feb. 13, 2009 (GLOBE NEWSWIRE) -- GeneThera, Inc. (Pink Sheets:GTHR), a leading international biotechnology company dedicated to improving food safety, will attend the Western Veterinary Conference February 15-19th in Las Vegas.
]]>https://www.globenewswire.com/news-release/2009/02/10/392361/159327/en/GeneThera-s-E-Coli-Vaccine-Featured-on-CBS-Channel-4-News-In-Denver-Colorado.html?f=22&fvtc=4&fvtv=6176GeneThera's E. Coli Vaccine Featured on CBS, Channel 4 News In Denver, Colorado2009-02-10T13:50:00Z<![CDATA[GeneThera Identifies Need for Government Action to Prevent Future E. Coli Outbreaks DENVER, SAN JOSE, Calif. and BOISE, Idaho, Feb. 10, 2009 (GLOBE NEWSWIRE) -- GeneThera, Inc. (Pink Sheets:GTHR), a leading international biotechnology company dedicated to improving food safety, was recently interviewed on Denver CBS Affiliate Channel 4, KCNC-TV. The interview was conducted as a result of an E. Coli outbreak linked to the National Western Stock Show.
]]>https://www.globenewswire.com/news-release/2009/02/09/392281/159239/en/GeneThera-Issues-February-Letter-to-Shareholders-and-Updates-Activities.html?f=22&fvtc=4&fvtv=6176GeneThera Issues February Letter to Shareholders and Updates Activities2009-02-09T14:10:00Z<![CDATA[WHEAT RIDGE, Colo., Feb. 9, 2009 (GLOBE NEWSWIRE) -- GeneThera, Inc. (Pink Sheets:GTHR), a leading international biotechnology company dedicated to improving food safety, announced its February Letter to Shareholders summarizing recent activity and corporate events.
]]>https://www.globenewswire.com/news-release/2006/12/18/352522/110523/en/GeneThera-to-Offer-DNA-Identification-Workshops-in-Their-Colorado-Laboratory.html?f=22&fvtc=4&fvtv=6176GeneThera to Offer DNA Identification Workshops in Their Colorado Laboratory2006-12-18T21:05:00Z<![CDATA[WHEAT RIDGE, Colo., Dec. 18, 2006 (PRIME NEWSWIRE) -- GeneThera, Inc. (OTCBB:GTHA) is pleased to announce that they will be offering workshops for individuals interested in learning the theory and methodology behind CODIS-based human DNA identification, the basis of paternity and forensic casework. Different levels of courses for non-scientists and scientists (towards continuing education credits) will be available with different levels of technical information presented. Both types of courses will utilize buccal cell swab samples from individuals who will perform laboratory exercises to extract DNA, amplify by PCR and detect STR targets by capillary electrophoresis. All procedures are kit-based with very well-established protocols to allow individuals to obtain their own CODIS DNA profiles, along with associated lectures. Lectures and laboratory work for these sessions will be directed and taught by scientists with extensive experience in this molecular biology application.
]]>https://www.globenewswire.com/news-release/2006/12/15/352518/110510/en/ApiGen-to-Begin-Marketing-Trial.html?f=22&fvtc=4&fvtv=6176ApiGen to Begin Marketing Trial2006-12-15T21:56:29Z<![CDATA[WHEAT RIDGE, Colo., Dec. 15, 2006 (PRIME NEWSWIRE) -- ApiGen (OTCBB:GTHA), the new company formed between GeneThera and Nutricion Avanzada in Monterrey, Mexico, is pleased to announce the beginning of a Marketing Trial in Mexico. The Marketing Trial will begin in the first quarter of 2007 with the testing of dairy cattle in Mexico for Johne's Disease. ApiGen estimates revenue for 2007 to be $8.8 million.
]]>https://www.globenewswire.com/news-release/2006/10/26/350156/107541/en/GeneThera-Orders-Multiple-State-of-the-Art-Robotic-PCR-Analysis-Machines-for-Use-in-Their-Mad-Cow-Testing-Laboratories.html?f=22&fvtc=4&fvtv=6176GeneThera Orders Multiple State of the Art Robotic PCR Analysis Machines for Use in Their Mad Cow Testing Laboratories2006-10-26T14:36:49Z<![CDATA[WHEAT RIDGE, Colo., Oct. 26, 2006 (PRIMEZONE) -- GeneThera, Inc. (OTCBB:GTHA) today announced that the Company has purchased three Tecan Freedom EVO(r) 200 systems for installation in the Company's Italian, Mexican and Colorado laboratory facilities. Once installed, GeneThera will have the ability to begin the validation process for its Mad Cow Disease Live Animal Assay as well as other veterinary diseases as previously announced.
]]>